Corpus Intelligence IC Memo — COMMUNITY MEMORIAL HOSPITAL 2026-04-26 06:41 UTC
IC Memo — COMMUNITY MEMORIAL HOSPITAL
Investment Committee Memorandum | VA | 66 beds | Grade B | EBITDA uplift $9.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

COMMUNITY MEMORIAL HOSPITAL

CCN 490098 | MECKLENBURG, VA | 66 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

COMMUNITY MEMORIAL HOSPITAL is a 66-bed under-performing / distressed in MECKLENBURG, VA with $135.2M in net patient revenue and a -31.0% operating margin. The hospital serves a payer mix of 36.5% Medicare, 2.4% Medicaid, and 61.1% commercial.

Thesis: Turnaround. Our ML models identify $9.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -31.0% to -23.6% (+736bps).

Net Revenue HCRIS$135.2M
Current EBITDA COMPUTED$-41.9M
Operating Margin COMPUTED-31.0%
Occupancy HCRIS61.9%
Revenue / Bed COMPUTED$2.0M
Net-to-Gross HCRIS27.5%
Distress Probability ML43.7%

2. Market Context & Competitive Position

111
VA Hospitals
4.4%
State Median Margin
56
Comparable Hospitals

VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of -31.0% places it below the state median. Among 56 size-comparable peers (33-132 beds), the median margin is 5.9%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (33-132), prioritizing same-state peers. 56 hospitals in the comp set.

HospitalStateBedsRevenueMargin
COMMUNITY MEMORIAL HOSPITAL (Target)VA66$135.2M-31.0%
ST. FRANCIS MEDICAL CENTERVA128$339.6M8.6%
CARILION NEW RIVER VALLEY MED VA94$261.3M-0.5%
RICHMOND COMMUNITY HOSPITALVA96$254.9M21.5%
SENTARA WILLIAMSBURG REGIONAL VA123$192.2M-4.9%
UVA HEALTH PRINCE WILLIAM MEDIVA106$191.7M-7.4%
JOHNSTON MEMORIAL HOSPITALVA100$188.3M6.1%
MARY IMMACULATE HOSPITALVA114$184.6M0.8%
LONESOME PINE HOSPITALVA56$175.6M17.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.8M+210bp18mo
Cost to Collect4.5%2.5%$2.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.6M+122bp9mo
Clean Claim Rate88.0%96.0%$86K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.8M
Cost to Collect
$2.7M
Denial Rate Reduction
$2.7M
A/R Days Reduction
$1.6M
Clean Claim Rate
$86K
Total EBITDA Uplift$9.9M
Current EBITDA$-41.9M
+ RCM Uplift+$9.9M
Pro Forma EBITDA$-32.0M
Current Margin-31.0%
Pro Forma Margin-23.6%
WC Released (1x)$5.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-64.5M$-177.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-64.5M$-215.6M0.00x-100.0%
Bull Case9.0x11.0x$-58.0M$-203.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-58.0M$-239.4M0.00x-100.0%
Bear Case11.0x10.0x$-70.9M$-205.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-70.9M$-249.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 56 hospitals with 33-132 beds
  • Same-state prioritization (n=57)
  • Comp margins: P25=-9.0% / P50=5.9% / P75=15.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.